Sandy Blackadder Primrose
Président chez Cellexus Ltd.
Profil
Sandy Blackadder Primrose is currently the Chairman at Arquer Diagnostics Ltd., Cellexus Ltd., Glycoscoredx Ltd., and a Trustee at The Pirbright Institute.
In the past, he served as Chairman at Arrayjet Ltd.
and Fios Genomics Ltd., Technical Director at GE Healthcare Ltd.
(United Kingdom), Non-Executive Director at Health Protection Agency and Lab901 Ltd., Biotechnology Director at the University of Warwick, Senior Director-Drug Development at Searle Research & Development, Director-Microbiological Research Authority at The National Archives, and Chief Operating Officer & VP-European Operations at Azur Environmental.
He also briefly served as a Non-Executive Director at Altimmune UK Ltd.
in 2010.
Postes actifs de Sandy Blackadder Primrose
| Sociétés | Poste | Début |
|---|---|---|
| Cellexus Ltd. | Président | - |
Arquer Diagnostics Ltd.
 Arquer Diagnostics Ltd. Medical/Nursing ServicesHealth Services Arquer Diagnostics Ltd. develops proprietary diagnostic immunoassays for the detection of prostate and bladder cancer using urine samples. Its develops non-invasive, urine-based ELISA and Point-of Care tests meet the increased demand for cost-effective healthcare technologies that not only enhance patient care but help to reduce overall healthcare costs by improving patient outcomes. The firm will commercialise ELISA and point-of-care urine tests for prostate and bladder cancer for use in the urology clinic, hospital lab and the GP’s surgery. The company was founded by David Nicholas Miller-Jones and William Dawson in 2007 and is headquartered in Sunderland, the United Kingdom. | Président | - |
The Pirbright Institute
 The Pirbright Institute Miscellaneous Commercial ServicesCommercial Services The Pirbright Institute, founded in 1914, is based in Woking, UK. The institute specializes in preventing and controlling viral diseases of livestock and those that spread from animals to people. The British company's facilities and capabilities provide opportunities for collaboration with other institutes and industries in research, data analysis, training, and access to some areas on-site. The institute offers a range of products, including positive sera, inactivated antigens, diagnostic kits, viral cultures, and live midges. The non-profit company's high containment facilities are internationally groundbreaking in design and maintenance, and they provide consultancy in architecture, engineering, and highly specialized expertise in risk and assurance. The diagnostic development team works with the world reference laboratory for foot-and-mouth disease at the Pirbright Institute and external partners to provide diagnostic products for foot-and-mouth disease (FMD), swine vesicular disease (SVD), and peste des petit ruminants (PPR). | Directeur/Membre du Conseil | - |
Glycoscoredx Ltd.
 Glycoscoredx Ltd. Miscellaneous Commercial ServicesCommercial Services Glycoscoredx Ltd. develops a novel blood test that revolutionizes how prostate cancer is diagnosed. The company is based in Newcastle upon Tyne, UK. The British company was founded in 2020 by Jennifer Munkley. Allan Brown has been the CEO of the company since 2020. | Directeur/Membre du Conseil | - |
Anciens postes connus de Sandy Blackadder Primrose
| Sociétés | Poste | Fin |
|---|---|---|
| The National Archives | Corporate Officer/Principal | - |
Arrayjet Ltd.
 Arrayjet Ltd. Industrial MachineryProducer Manufacturing Arrayjet Ltd. develops and produces microarray printing technologies for researchers, drug development groups, and diagnostic companies. Its products include Sprint, Marathon and Super Marathon, Ultra Marathon I and II Microarrayers. The company was founded by Howard John Manning, Peter Ghazal and Douglas Roy in 2000 and is headquartered in Roslin, the United Kingdom. | Président | - |
| Health Protection Agency | Directeur/Membre du Conseil | - |
Lab901 Ltd.
 Lab901 Ltd. Medical SpecialtiesHealth Technology At Lab901 the management believe that your time should be dedicated to discovery, not manual and repetitive tasks. Lab901 was founded in 2001 to deliver this vision. Its team combines expertise in automation, electrophoresis, software development and molecular biology biochemistry. The company is proud to introduce ScreenTape, the first fully automated platform for gel electrophoresis. | Directeur/Membre du Conseil | - |
Fios Genomics Ltd.
 Fios Genomics Ltd. Data Processing ServicesTechnology Services Fios Genomics Ltd. provides genomic and bioinformatics data analysis services. It offers access to a combined resource of in-house bioinformaticians, statisticians and biologists working together to analyze, interpret genomic, transcriptomic and proteomic data. The company was founded by Peter Ghazal in 2008 and is headquartered in Edinburgh, the United Kingdom. | Président | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 13 |
|---|---|
Azur Environmental
 Azur Environmental Electronic Equipment/InstrumentsElectronic Technology Azur Environmental provides analytical systems for monitoring water. The company was founded on December 18, 1984 and is headquartered in Carlsbad, CA. | Electronic Technology |
GE Healthcare Ltd. (United Kingdom)
 GE Healthcare Ltd. (United Kingdom) Medical SpecialtiesHealth Technology GE Healthcare Ltd. provides transformational medical technologies and services which include icenter, AssetPlus, preventive maintenance, continuity, digital solutions and Unisys multi brand probe repair services. The firm offers magnetic resonance imaging, hemodynamic recording, EP recording, metabolic health and computed tomography. The company was founded on February 16, 1971 and is headquartered in Little Chalfont, the United Kingdom. | Health Technology |
| Health Protection Agency | Government |
Lab901 Ltd.
Lab901 Ltd. Medical SpecialtiesHealth Technology At Lab901 the management believe that your time should be dedicated to discovery, not manual and repetitive tasks. Lab901 was founded in 2001 to deliver this vision. Its team combines expertise in automation, electrophoresis, software development and molecular biology biochemistry. The company is proud to introduce ScreenTape, the first fully automated platform for gel electrophoresis. | Health Technology |
Altimmune UK Ltd.
 Altimmune UK Ltd. BiotechnologyHealth Technology Altimmune UK Ltd. engages in the discovery and development of prophylactic and therapeutic vaccines against mutating viruses and cancer. It provides T-cell vaccines to protect patients against infectious diseases (most notably mutating viruses) and to treat cancers; and Flunisyn, a DepoVaccine to protect against influenza. The company was founded by Bertrand Georges in 2003 and is headquartered in London, the United Kingdom. | Health Technology |
Arrayjet Ltd.
Arrayjet Ltd. Industrial MachineryProducer Manufacturing Arrayjet Ltd. develops and produces microarray printing technologies for researchers, drug development groups, and diagnostic companies. Its products include Sprint, Marathon and Super Marathon, Ultra Marathon I and II Microarrayers. The company was founded by Howard John Manning, Peter Ghazal and Douglas Roy in 2000 and is headquartered in Roslin, the United Kingdom. | Producer Manufacturing |
| Searle Research & Development | |
| The National Archives | Government |
Arquer Diagnostics Ltd.
Arquer Diagnostics Ltd. Medical/Nursing ServicesHealth Services Arquer Diagnostics Ltd. develops proprietary diagnostic immunoassays for the detection of prostate and bladder cancer using urine samples. Its develops non-invasive, urine-based ELISA and Point-of Care tests meet the increased demand for cost-effective healthcare technologies that not only enhance patient care but help to reduce overall healthcare costs by improving patient outcomes. The firm will commercialise ELISA and point-of-care urine tests for prostate and bladder cancer for use in the urology clinic, hospital lab and the GP’s surgery. The company was founded by David Nicholas Miller-Jones and William Dawson in 2007 and is headquartered in Sunderland, the United Kingdom. | Health Services |
Fios Genomics Ltd.
Fios Genomics Ltd. Data Processing ServicesTechnology Services Fios Genomics Ltd. provides genomic and bioinformatics data analysis services. It offers access to a combined resource of in-house bioinformaticians, statisticians and biologists working together to analyze, interpret genomic, transcriptomic and proteomic data. The company was founded by Peter Ghazal in 2008 and is headquartered in Edinburgh, the United Kingdom. | Technology Services |
The Pirbright Institute
The Pirbright Institute Miscellaneous Commercial ServicesCommercial Services The Pirbright Institute, founded in 1914, is based in Woking, UK. The institute specializes in preventing and controlling viral diseases of livestock and those that spread from animals to people. The British company's facilities and capabilities provide opportunities for collaboration with other institutes and industries in research, data analysis, training, and access to some areas on-site. The institute offers a range of products, including positive sera, inactivated antigens, diagnostic kits, viral cultures, and live midges. The non-profit company's high containment facilities are internationally groundbreaking in design and maintenance, and they provide consultancy in architecture, engineering, and highly specialized expertise in risk and assurance. The diagnostic development team works with the world reference laboratory for foot-and-mouth disease at the Pirbright Institute and external partners to provide diagnostic products for foot-and-mouth disease (FMD), swine vesicular disease (SVD), and peste des petit ruminants (PPR). | Commercial Services |
Glycoscoredx Ltd.
Glycoscoredx Ltd. Miscellaneous Commercial ServicesCommercial Services Glycoscoredx Ltd. develops a novel blood test that revolutionizes how prostate cancer is diagnosed. The company is based in Newcastle upon Tyne, UK. The British company was founded in 2020 by Jennifer Munkley. Allan Brown has been the CEO of the company since 2020. | Commercial Services |
| Cellexus Ltd. |
